Garry Flounders

Garry Flounders is an experienced professional specializing in pharmacovigilance and operations within the pharmaceutical industry. Currently serving as Associate Director and Global Pharmacovigilance Operation Lead for Biosimilars at Biogen since June 2022, Garry has held various managerial roles including with Panacea as EU QPPV & QPPV Services Regional Manager and with PharmaLex as Associate Director. Previous experience includes positions at Regulis Consulting Ltd, DIAMOND PHARMA CONSULTING LTD, PrimeVigilance Ltd as Director of Operations, Covance, Worldwide Clinical Trials, Genzyme as Pharmacovigilance Manager, and Cancer Research UK. Garry holds a BSc in Biological Science from Lancaster University and a PgC in Biomedical Science from the University of Westminster.